Previous Close | 2.1800 |
Open | 2.1700 |
Bid | 2.1100 x 100 |
Ask | 2.1500 x 200 |
Day's Range | 2.1100 - 2.2200 |
52 Week Range | 1.3300 - 4.2980 |
Volume | |
Avg. Volume | 352,722 |
Market Cap | 82.019M |
Beta (5Y Monthly) | 2.84 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.0900 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.42 |
NEW YORK, NY / ACCESSWIRE / May 7, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 8-9, 2024. The ...
BOTHELL, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the following upcoming investor conferences in May. Sidoti May 2024 Virtual Investor ConferenceFormat: Company PresentationDate and Time: Wednesday, May 8, 2024, from 10:45 a.m. - 11:15 a.m. ET Location: Virtual Th
Viewing insider transactions for Athira Pharma, Inc.'s ( NASDAQ:ATHA ) over the last year, we see that insiders were...